On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Series A – A-Alpha Bio
On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Post-IPO Equity – Biostage
On Sep 8, 2021 Biostage closed a Post-IPO Equity round and raised $2,600,000 from investors, featuring lead investors . About the company: Biostage is located […]
Vector Laboratories acquired by Thompson Street Capital Partners
Sep 7, 2021 Thompson Street Capital Partners has entered into an agreement to acquire Vector Laboratories . Thompson Street Capital Partners based at St Louis, […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Series A – Via Nova Therapeutics
On Sep 7, 2021 Via Nova Therapeutics closed a Series A round and raised $20,000,000 from Aditum Bio, featuring lead investors Aditum Bio. About the […]
Series A – EnteroBiotix
On Sep 7, 2021 EnteroBiotix closed a Series A round and raised £15,500,000 from Kineticos Ventures, Scottish Enterprise, SIS Ventures, Thairm Bio, featuring lead investors […]
